Drug Profile
SDN 289
Latest Information Update: 27 Sep 2006
Price :
$50
*
At a glance
- Originator Sindan
- Class
- Mechanism of Action Estrogen receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Breast cancer
Most Recent Events
- 27 Sep 2006 Discontinued - Preclinical for Breast cancer in Romania (unspecified route)
- 04 Dec 2000 Preclinical development for Breast cancer in Romania (Unknown route)